Somatrogon

Generic Name
Somatrogon
Brand Names
Ngenla
Drug Type
Biotech
Chemical Formula
-
CAS Number
1663481-09-1
Unique Ingredient Identifier
6D848RA61B
Background

Somatrogon is a long-acting recombinant human growth hormone. Growth hormone is a peptide hormone secreted by the pituitary gland that plays a crucial role in promoting longitudinal growth during childhood and adolescence and regulating metabolic function in adulthood. Recombinant growth hormone therapy for growth hormone deficiency and other conditions has ...

Indication

Somatrogon is indicated for the long-term treatment of pediatric patients who have growth failure due to an inadequate secretion of endogenous growth hormone (growth hormone deficiency).

Associated Conditions
Growth Failure
Associated Therapies
-
Clinical Trials
Related News

A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.

Not yet recruiting
Conditions
Dwarfism, Pituitary
Interventions
Drug: Somatrogon
First Posted Date
2024-09-19
Last Posted Date
2024-12-18
Lead Sponsor
Pfizer
Target Recruit Count
100
Registration Number
NCT06587035

Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD

Phase 3
Completed
Conditions
Growth Hormone Deficiency
Interventions
Drug: Genotropin
Drug: somatrogon
First Posted Date
2019-02-06
Last Posted Date
2021-10-14
Lead Sponsor
Pfizer
Target Recruit Count
87
Registration Number
NCT03831880
Locations
🇺🇸

Hackensack University Medical Center, Hackensack, New Jersey, United States

🇸🇰

Národný ústav detských chorôb, Detská klinika, Bratislava, Slovakia

🇺🇸

Shriners Hospitals for Children, Tampa, Florida, United States

and more 29 locations

A Clinical Study Investigating the Comparability of Somatrogon in Two Different Drug Product Presentations

Phase 1
Completed
Conditions
Healthy Male Volunteers
Interventions
Drug: Somatrogon
First Posted Date
2019-01-22
Last Posted Date
2020-04-28
Lead Sponsor
OPKO Health, Inc.
Target Recruit Count
49
Registration Number
NCT03810664
Locations
🇺🇸

QPS Miami Research Associates, Miami, Florida, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy